Comparative effects of drugs on four paw oedema models in the rat
- 35 Downloads
The development of novel anti-inflammatory drugs (AID) has been claimed to be dependent on the discovery of models of inflammation that differ from those currently used for drug screening, e.g. carrageenen paw oedema and u.v. erythema. We have thus evaluated the effect of a variety of drugs in a number of novel models of inflammation in the rat produced in the hind paw. We have utilized kaolin, zymosan, anti-rat IgG (anti-IgG) and the Reversed Passive Arthus (RPA) reaction to produce these oedema models.
We found that the non-steroidal AID's, e.g. aspirin, flufenamic acid, indomethacin, naproxen and phenylbutazone, were active in all four tests. Of the nine novel AID examined, levamisole and tetramisole demonstrated considerable activity in all four tests and dapsone was especially active in the anti-IgG and RPA tests. In contrast, the anti-rheumatic d-penicillamine was inactive in all four models. Each of the ten compounds tested which has been claimed to influence complement function, was active in the RPA but not in the kaolin model. These results are discussed in the context of the aetiology of each oedema and the suspected mode of action of the various drugs.
KeywordsAspirin Indomethacin Naproxen Kaolin Levamisole
Unable to display preview. Download preview PDF.
- P. Bresloff,Miscellaneous Antirheumatic Drugs and Their Possible Models of Action, in:Advances in Drug Research, vol. 11 (Academic Press, London, New York and San Francisco, 1977), pp. 1–21.Google Scholar
- D. A. Willoughby andP. Dieppe,Anti-Inflammatory Models in Animals, in:Future Trends in Inflammation, vol. 11 (Birkhäuser Verlag, Basel and Stuttgart, 1975), pp. 306–312.Google Scholar
- N. J. Zwaifler,Rheumatoid Synovitis. An Extravascular Immune Complex Disease, Arthritis Rheum.17, 29–305 (1974).Google Scholar
- A. C. Allison andP. Davies,Mechanisms Underlying Chronic Inflammation, in:Future Trends in Inflammation, vol. 1 (Piccin Books, London, 1974), pp. 449–480.Google Scholar
- G. W. Carter andR. A. Krause,The Reversed Passive Arthus Reaction in the Rat: a Potential Screen for Anti-Inflammatory Agents, Fed. Proc.35, 774 (1976).Google Scholar
- J. Noordhoek, M. R. Nagy andI. L. Bonta,Involvement of Complement and Kinins in Some Non-Immunogenic Paw Inflammations in Rats, in:I. L. Bonta,Recent Developments in the Pharmacology of Inflammatory Mediators (Birkhäuser Verlag, Basel and Stuttgart, 1977), pp. 109–121.Google Scholar
- E. C. Keystone, C. P. Schorlemmer, C. Pope andA. C. Allison,Zymosan-Induced Arthritis. A Model of Chronic Proliferative Arthritis Following Activation of the Alternative Pathway of Complement, Arth. Rheum.20, 1396–1401 (1977).Google Scholar
- M. B. Goldlust, T. W. Harrity andD. M. Palmer,Evaluation of Anti-rheumatic drugs Using the Cutaneous Arthus Reaction, in:D. C. Dumonde andM. K. Jasani,The Recognition of Anti-Rheumatic Drugs (M.T.P. Press Ltd., Lancaster, 1978), pp. 119–136.Google Scholar
- C. G. Cochrane,The Arthus and Related Reactions, inC. A. Williams andM. W. Chase,Methods in Immunology and Immunochemistry, vol. V,Antigenantibody Reactions in Vivo (Academic Press, Inc., New York, San Francisco, London, 1976), pp. 159–175.Google Scholar
- K. Whaley, D. J. P. Sloane, A. G. Davidson andP. M. Brooks,Studies of the Action of Some Anti-Inflammatory Drugs on Complement Mediated Immune Haemolysis, Br. J. clin. Pharmac.2, 123–129 (1975).Google Scholar
- D. C. Atkinson, K. E. Godfrey, B. J. Jordan, E. C. Leach B. E. Meek, J. D. Nichols andJ. F. Saville,2-(2,4-Dichlorophenoxy) Phenylacetic Acid (Fenclofenac): One of a Novel Series of Anti-Inflammatory Compounds with Low Ulcerogenic Potential, J. Pharm. Pharmacol.26, 357–359 (1974).PubMedGoogle Scholar
- B. McConkey, P. Davies, R. A. Crockson, A. P. Crockson, M. Butler andT. J. Constable,Dapsone in Rheumatoid Arthritis, Rheum. Rehabil.15, 230–234 (1976).Google Scholar
- T.-S. Yeoh, E.-H. Yap, M. Singh andB.-C. Ho,Drug Inhibition of Anaphylactic Histamine Release from Peritoneal Cells of Rats Infected with Toxocara canis, Int. Archs. Allergy appl. Immunol.49, 371–380 (1975).Google Scholar
- T. di Perri, F. Auteri, F. L. Pasani andF. Mattioli,Biological, Chemical and Pharmacological Induction of the Properdin-Mediated Pathway of Complement Activation in Vitro, in:D. A. Willoughby,J. P. Giroud andG. P. Velo,Perspectives in Inflammation. Future Trends and Developments (M.T.P. Press Ltd., Lancaster, 1977), pp. 405–416.Google Scholar
- V. Eisen andC. Loveday,Effects of Suramin on Complement, Blood Clotting, Fibrinolysis and Kinin Formation, Br. J. Pharmac.49, 678–687 (1973).Google Scholar
- F. B. Taylor, andH. Fudenberg,Inhibition of the C 1 Component of Complement by Amino Acids, Immunology7, 319–331 (1964).Google Scholar